CIK 0000748592
- Non-accelerated filer
- Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 311103425
- Phone
- +1 617-798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Vice President of Finance gave up 179 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 261,756 shares at $3.28 ($858,560)
- 4 Open-market buy Director bought 283,286 shares at $3.28 ($929,178)
- 4 Open-market buy 10% owner bought 335,920 shares at $3.28 ($1,101,818)
- 4 Exercise or conversion Chief Medical Officer acquired 20,163 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Scientific Officer gave up 6,077 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President of Finance gave up 3,586 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 3 of 29 · 572 filings